Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis
Clinical trial NCT02102204 · COMPLETED
Trial details
- NCT number
- NCT02102204
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-25
- Primary completion
- 2016-11-04
- Enrollment
- 902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.